Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients
Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced a major milestone for its mission – the completion of […]